Top Software Companies With Best Stability & Growth (10,000+)

Profitability: FY26 adjusted EBITDA rose 14% to $357.8 million with a mid‑50s margin, indicating strong earnings power even as investments increase. Management also highlighted sustained profitability alongside product expansion.

Healthy Cash Flow: Free cash flow grew 19% year over year to $317.5 million in FY26, with Q4 FY26 free cash flow of $107.3 million up double digits. These trends suggest solid cash generation supporting reinvestment and capital flexibility.

Strong Market Position & Advantage: The platform reports over 3 million members and reach to more than 85% of U.S. physicians, with record engagement of 800,000+ active prescribers on workflow tools. This scale can attract healthcare and life‑science spend and underpins monetization.

Strong Revenue Growth: Results show quarterly revenue has surpassed $1B and full‑year guidance points to continued expansion. Feedback suggests momentum is sustained across recent periods rather than isolated to a single quarter.

Healthy Cash Flow: Disclosures indicate strong operating and free cash flow in the latest quarter, with substantial cash generation in the prior fiscal year. Feedback suggests this provides flexibility to invest while scaling.

Product Line Growth: Recent launches such as GPU Monitoring, Bits AI Security Analyst, and MCP Server expand the platform’s breadth into observability, security, and AI‑related workloads. Feedback suggests rising multi‑product adoption is deepening platform penetration.

Strong Revenue Growth: Recent disclosures highlight year-over-year revenue increases in 2025 and further growth in early 2026, with guidance pointing to continued double-digit expansion. Record analysis volumes and scaling usage underpin this top-line momentum.

Customer Loyalty & Retention: Net Dollar Retention improved and core genomics customers increased through 2025 into Q1 2026, indicating expanding spend and usage within the installed base. These trends suggest effective land-and-expand dynamics as newer applications drive deeper adoption.

Market Expansion: The company is adding a record number of new customers and expanding in the U.S., including large health-system wins and broader adoption of MSK-ACCESS/MSK-IMPACT. Rising platform analyses across regions signal broader geographic traction.

Investor Backing & Capital Strength: A majority strategic growth investment from Great Hill Partners in 2023, with Vista Equity Partners retaining a significant minority stake, signals strong capital support. Company communications frame this funding as fuel for go-to-market expansion and product innovation.

Innovation-Driven Growth: Recent launches such as Recovery Optimization, BC Plan inFusion, Resilience Copilot, and the Scenario Simulation & Intelligence suite indicate sustained roadmap velocity with an AI focus. These capabilities are positioned to improve planning, recovery, and decision-making for enterprise resilience programs.

Strategic Partnerships: Alliances like the PwC Netherlands collaboration and ecosystem integrations (e.g., AlertMedia) are emphasized as expanding reach and solution depth. Such partnerships typically support regulated-market entry and accelerate customer adoption.

Product Line Growth: Recent acquisitions of Planck and Cytora expanded AI/data and digital risk‑intake capabilities across the platform, alongside continued feature releases across Epic, EZLynx, Ivans, and Applied Pay. Conference and press activity point to steady rollouts, recognitions, and customer wins that broaden offerings for agencies, brokers, MGAs, and carriers.

Innovation-Driven Growth: Back‑to‑back AI‑focused deals and embedded AI features across the ‘Digital Roundtrip of Insurance’ indicate a roadmap anchored in automation and data‑driven workflows. Leadership transition plans explicitly frame the next stage around scaling AI‑led growth.

Strong Market Position & Advantage: Adoption momentum includes standardization by top brokers and growing traction for products like Applied Pay, supported by ecosystem engagement at Applied Net. Ongoing releases and industry recognitions suggest durable positioning across core agency/broker management systems.

Innovation-Driven Growth: Recent 2026 launches such as RethinkBH’s AI Dashboard and Session Note AI, alongside major RethinkCare enhancements, signal active investment in new capabilities. These moves emphasize AI-enabled features to expand value for ABA practices and employers.

Future-Ready Strategy: Leadership additions—including a new CEO in 2026 and multiple senior hires in 2025—are framed as steps to accelerate innovation and scale. This pattern aligns with a company preparing for its next phase of growth.

Strong Revenue Growth: Repeated inclusion on the Inc. 5000 through 2024 indicates sustained multi‑year revenue expansion leading up to those recognitions. While historical, these accolades corroborate a prior growth trajectory.

Strategic Partnerships: Recent public references show Supernova powering securities‑based lending for large wealth and bank platforms, and a 2024 agreement indicates R&T Deposit Solutions will transition existing loan‑management clients to its platform. These moves point to expanding distribution and net client additions.

Market Expansion: The company announced expansion into the United Kingdom in February 2026 to offer Lombard (securities‑based) lending. This demonstrates a growing geographic footprint beyond the U.S. wealth market.

Product Line Growth: Supernova markets an end‑to‑end, modular SBL stack and in 2024 introduced Aperture (collateral management) and Prism (an AI‑powered document assistant). These additions suggest continued investment in platform breadth and cross‑sell potential.

Investor Backing & Capital Strength: Recent funding of about $11M in October 2025 indicates capacity to invest in growth. This fresh capital aligns with stated expansion plans into 2026.

Innovation-Driven Growth: Product updates such as Version 5.0 entering beta in January 2025, including early support for the RESNET Carbon Rating Index, demonstrate ongoing R&D. This cadence reflects continued platform investment to meet evolving program standards.

Strong Market Position & Advantage: Company and industry materials cite a market-leader position, supported by surpassing one million rating submissions and powering RESNET builder data offerings. Continued inclusion on DOE/RESNET approved software lists shows entrenched role in compliance workflows.

Market Expansion: Public materials indicate expansion into Virginia, Washington, and Michigan beyond the original Tennessee, Ohio, and Florida, with phone lines and city-level coverage signaling active operations. Company partner materials also cite roughly 45,000 attributed lives across multiple states as evidence of scale.

Investor Backing & Capital Strength: Trade coverage notes GV led a $28.1M round in 2023, with subsequent references to continued investor support consistent with expansion. This capital base is presented as fueling launches and the build-out of operations.

Strategic Partnerships: Industry reports highlight value-based work with Carelon (Elevance) and references to Molina and other Medicaid managed care partners. These payer relationships underpin access to high-need populations and contract-driven growth.

Strong Revenue Growth: Recent quarters show meaningful year-over-year increases, with results exceeding guidance. Management raised near-term revenue outlook, indicating continued momentum.

Product Line Growth: AI and agentic-cloud launches and added capacity are cited as catalysts boosting demand. Larger-customer uptake alongside new AI offerings is expanding the monetization footprint.

Future-Ready Strategy: Leadership highlights AI-native capabilities and incremental capacity as foundations for higher growth targets into 2026–2027. Guidance lifts are attributed to momentum from new AI products supporting next-phase workloads.

Strong Revenue Growth: Public disclosures cite 2025 revenue around $2.19 billion with roughly 31% year-over-year growth and guidance for 2026 of approximately $2.63–$2.67 billion. Quarterly updates (e.g., Q1 and Q3 2025) also indicate high-twenties to low-thirties growth, reinforcing momentum.

Diversified Revenue Streams: Updates describe newer lines like MyPay, Outbound Instant Transfer, and secured/credit products with platform revenue scaling alongside core interchange. ARPAM improvement and mix shift toward higher-take-rate products suggest revenue is broadening beyond debit spend.

Strong Market Position & Advantage: Multiple sources frame Chime as a leading U.S. neobank by active members and share of new checking-account openings, with continued member growth through 2025–Q1 2026. The June 2025 IPO and subsequent investor guidance signal external validation of scale and outlook.

Investor Backing & Capital Strength: Public announcements detail a recent Series B led by notable investors, following an earlier Series A, providing material runway to scale. Funding confirmations on company and third‑party sites reinforce the availability of capital for product and go‑to‑market expansion.

Market Expansion: Company communications state that new capital will support entry into additional U.S. tax and accounting domains and the rebrand from SPRX to Onshore underscores broader ambitions. Feedback suggests offerings have broadened beyond a single credit, pointing to a wider footprint.

Diversified Customer Base: The site highlights support for 500+ companies across multiple sectors and substantial incentives identified, indicating usage across varied industries. These references imply demand from technology, energy, manufacturing, architecture, and agriculture customers rather than concentration in a single vertical.

Investor Backing & Capital Strength: Recent funding trackers indicate a fresh 2025 round of about $26.35M, bringing total capital raised to roughly $76M—providing fuel to scale product and go‑to‑market.

Market Expansion: Multiple 2025–2026 manufacturer and distributor notices show transitions to Truzo (e.g., Alkermes, Organon, Gilead via Cencora). These migrations suggest growing adoption across stakeholders.

Product Line Growth: Kalderos promotes Truzo as an end‑to‑end drug discount management platform and continues to enhance solutions like Discount Hub and Commercial Discount Monitoring. Industry commentary and company materials highlight expanding capabilities aligned to today’s 340B environment.

Strong Revenue Growth: Public disclosures indicate Lob surpassed the $100M revenue mark by April 2023 with strong year-over-year momentum. This milestone, alongside reported customer gains around that period, signals material commercial scaling.

Strong Market Position & Advantage: Recognition from the USPS at the 2024 National Postal Forum and emphasis on a national print network with USPS program integrations point to credibility and scale within the postal ecosystem. These ecosystem ties and platform breadth reinforce a defensible position in direct mail automation.

Market Expansion: Company materials through 2024–2026 cite “over 12,000 businesses” using the platform, up from earlier figures. This consistent adoption language indicates ongoing expansion of the customer footprint.

Strong Revenue Growth: Public rankings such as FT Americas 2026, Inc. Regionals 2026, and Inc. 5000 (2025) indicate sustained multi‑year revenue expansion. Feedback suggests momentum continued post‑acquisition with external recognition persisting into 2026.

Strategic Partnerships: Repeated Datadog Partner of the Year wins and a 2026 Innovation in Services award, alongside ServiceNow Elite status, indicate strong, monetizable alliances. Datadog’s criteria include revenue contribution and growth, signaling commercial impact from these relationships.

Innovation-Driven Growth: Recent launches around AI and productized offerings (e.g., agentic/AI solutions and packaged services) reflect ongoing investment in new growth vectors. Feedback suggests active product/marketing activity and marketplace presence are expanding reach.

Investor Backing & Capital Strength: Public launch materials indicate a $49M seed round co-led by ICONIQ and CRV, with ICONIQ also incubating the company. This capital is positioned to fund hiring, product development, and early deployments.

Strong Hiring & Retention: Job postings on the careers page and recent LinkedIn listings show active recruiting across engineering, product, and operations in New York. These signals point to near-term headcount expansion following the launch.

Innovation-Driven Growth: Product descriptions highlight an AI-first service management platform with a live organizational graph (Axiom) and early work with enterprise design partners. This innovation focus aligns with plans for accelerated product development and deployments.

Product Line Growth: The acquisition of VaultOne added privileged access management to the platform, broadening the offering and cross-sell surface. This extends JumpCloud’s ability to serve more of the identity stack from a single platform.

Strategic Partnerships: Deeper collaboration with Google—co-launching a Work Transformation Set and later receiving a 2026 Google Cloud Partner of the Year award—signals expanding enterprise channel reach. These ties can catalyze larger opportunities within the Google Workspace ecosystem.

Future-Ready Strategy: Joining the OpenID Foundation as a Sustaining Corporate Member and launching a corporate venture arm reflect standards engagement and longer-horizon growth bets. Steady 2025–2026 shipping cadence across identity and device management underpins this trajectory.

Strong Revenue Growth: Reported FY26 results and quarterly updates show sustained double‑digit increases in revenue and ARR from a large base. Forward commentary indicates momentum carried into the start of FY27.

Profitability: The company achieved consecutive GAAP‑profitable quarters and highlighted positive adjusted free cash flow and improving margins. Management characterizes unit economics as improving year over year.

Innovation-Driven Growth: Rising multi‑product adoption and rapidly expanding data processed on the platform are credited with driving upsell and retention. New AI‑led and emerging products are cited as contributing meaningfully to net new ARR.

Market Expansion: Company materials describe operations in 20+ states with thousands of patients supported and completed service requests as of April 2025. These figures indicate expansion beyond a single‑state footprint.

Investor Backing & Capital Strength: Public trackers and filings indicate seed‑stage capital beyond the early 2021 raise, including roughly $2.87M around 2023–2024 and prior 2022 funding. This level of funding typically underwrites expansion.

Innovation-Driven Growth: The company announced SOC 2 Type I certification (Nov 27, 2023) and touts a platform patent (May 12, 2025), alongside recognition such as TAG Top 10 Innovative Companies of 2025. These developments signal an innovation‑led scaling posture.

Strategic Partnerships: Recent tie-ups with WisdomTree, Ironlight, NewEdge and others point to expanding distribution and new issuance rails. These collaborations indicate a pipeline to scale across advisor channels and product formats.

Market Expansion: Regulatory authorization and ongoing activity in Abu Dhabi’s ADGM, plus the Majarra technology partnership, signal deepening presence in the Middle East. These developments suggest geographic diversification beyond the U.S. market.

Product Line Growth: New offerings such as structured‑note SMAs, annuities with multiple carriers, portfolio analytics (Aura), and tokenized notes broaden the platform’s capabilities. This breadth can support adoption across more client use cases and revenue streams.